Results 91 to 100 of about 9,412 (255)

2083 Mesalamine-Induced Myocarditis

American Journal of Gastroenterology, 2019
INTRODUCTION: Mesalamine is a widely used medication for treatment in patients with ulcerative colitis (UC). A rare adverse effect (AE) is mesalamine-induced myocarditis (MIM). A high index of suspicion is essential for prompt diagnosis and prevention of significant morbidity.
Kambiz Kadkhodayan, Tyler Putnam, Erica P. Turse   +2 more
openaire   +3 more sources

Mesalamine in pediatric inflammatory bowel disease: A 10-year experience [PDF]

, 1996
Ian D. DʼAgata, Tsafrir Vanounou, Ernest G. Seidman   +2 more
openalex   +1 more source

Mesalamine: Safe at first look [PDF]

Inflammatory Bowel Diseases, 1999
Jacqueline L. Wolf, Lawrence J. Saubermann   +1 more
openaire   +3 more sources

Endoscopic and clinicopathological features of segmental colitis associated with diverticulosis

DEN Open
Objectives Segmental colitis associated with diverticulosis (SCAD) has close endoscopic and pathological similarities to ulcerative colitis (UC) and Crohn's disease. Clinical data on SCAD are limited in Japan.
Kazuhiko Obata, Kan Uchiyama, Ryuzo Murai   +2 more
doaj   +1 more source

Mesalamine for the prevention of postoperative recurrence: Is nearly there the same as being there? [PDF]

, 2000
Lloyd R. Sutherland
openalex   +1 more source

Oral mesalamine prodrug approved for active ulcerative colitis [PDF]

, 2000
John L. Miller
openalex   +1 more source

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide [PDF]

, 2001
Philip W. Lowry
openalex   +1 more source

Measurement of Colonic Mucosal Concentrations of 5-Aminosalicylic Acid Is Useful for Estimating Its Therapeutic Efficacy in Distal Ulcerative Colitis: Comparison of Orally Administered Mesalamine and Sulfasalazine [PDF]

, 2001
Makoto Naganuma, Yasushi Iwao, Haruhiko Ogata, Nagamu Inoue, Shinsuke Funakoshi, Shojirou Yamamoto, Y. Nakamura, Hiromasa Ishii, Toshifumi Hibi∥   +8 more
openalex   +1 more source

A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis [PDF]

, 2003
Sunanda V. Kane, Dezheng Huo, Kalyani Magnanti   +2 more
openalex   +1 more source

A Practical Approach to Identify Non-Adherence to Mesalamine Therapy in Inflammatory Bowel Disease

Gastroenterology Insights
Introduction: Adherence to mesalamine therapy in ulcerative colitis is often inadequate. This affects long-term remission and to some extent the risk of colon cancer.
Filippo Vernia, Giorgia Burrelli Scotti, Raffaele Borghini, Mario Muselli, Stefano Necozione, Giovanni Moretta, Lorenza Scurti, Giuseppe Donato   +7 more
doaj   +1 more source